{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["42(2)"],"submitter":["Gonzalez-Chica D"],"pubmed_abstract":["<h4>Introduction</h4>We aimed to explore trends and sociodemographic patterns in benzodiazepine (BZD) (by half-life) and Z-drugs prescribing in Australian general practice.<h4>Methods</h4>This open cohort study used de-identified electronic health records of 1.4 million patients (50,812,413 consultations) from 402 Australian practices (MedicineInsight 2011-2018). Annual prescribing frequency and changes over time were estimated according to sex, age, socioeconomic position and rurality.<h4>Results</h4>Between 2011 and 2018, the prescribing of very short-acting BZD increased from 0.10 to 0.29 per 1000 consultations (average annual change +17.2% [95% CI 9.6; 25.3]), while it declined for short-intermediate (from 38.5 to 26.6 per 1000 consultations; annual change -5.1% [95% CI -5.6; -4.5]), l"],"journal":["Drug and alcohol review"],"pagination":["427-438"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10092554"],"repository":["biostudies-literature"],"pubmed_title":["Trends and patterns of benzodiazepines and Z-drugs prescriptions in Australian general practice: A national study (2011-2018)."],"pmcid":["PMC10092554"],"pubmed_authors":["Bernardo C","Sweetman A","Gonzalez-Chica D","Hoon E","Stocks N","Begum M"],"additional_accession":[]},"is_claimable":false,"name":"Trends and patterns of benzodiazepines and Z-drugs prescriptions in Australian general practice: A national study (2011-2018).","description":"<h4>Introduction</h4>We aimed to explore trends and sociodemographic patterns in benzodiazepine (BZD) (by half-life) and Z-drugs prescribing in Australian general practice.<h4>Methods</h4>This open cohort study used de-identified electronic health records of 1.4 million patients (50,812,413 consultations) from 402 Australian practices (MedicineInsight 2011-2018). Annual prescribing frequency and changes over time were estimated according to sex, age, socioeconomic position and rurality.<h4>Results</h4>Between 2011 and 2018, the prescribing of very short-acting BZD increased from 0.10 to 0.29 per 1000 consultations (average annual change +17.2% [95% CI 9.6; 25.3]), while it declined for short-intermediate (from 38.5 to 26.6 per 1000 consultations; annual change -5.1% [95% CI -5.6; -4.5]), l","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Feb","modification":"2025-04-20T02:23:00.016Z","creation":"2025-04-20T02:23:00.016Z"},"accession":"S-EPMC10092554","cross_references":{"pubmed":["36217261"],"doi":["10.1111/dar.13561"]}}